-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RD-1302 in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RD-1302 in Refractory Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RD-1302 in Refractory Acute Myeloid Leukemia Drug Details: RD13-02...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RD-1302 in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RD-1302 in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RD-1302 in Relapsed Acute Myeloid Leukemia Drug Details: RD13-02...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RD-1302 in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RD-1302 in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RD-1302 in T-Cell Acute Lymphocytic...
-
Product Insights
Likelihood of Approval Analysis for Respiratory Distress Syndrome
Overview How likely is it that the drugs in Respiratory Distress Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Respiratory Distress Syndrome Overview Respiratory distress syndrome (RDS) occurs in babies...
-
Product Insights
Martin Rd Solar PV Park
Martin Rd Solar PV Park is a solar PV project located in New York, United States. The project is owned by Olivewood Energy LLC and is developed by Martin Rd Solar LLC. The project is at the permitting stage. Empower your strategies with our Martin Rd Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of...
-
Product Insights
Watkins Rd Solar PV Park
Watkins Rd Solar PV Park is a solar PV project located in New York, United States. The project is owned and being developed by SunEast Development LLC. The project is at the permitting stage. Empower your strategies with our Watkins Rd Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Insulin Degludec LA in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Insulin Degludec LA in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Insulin Degludec LA in Type 2 Diabetes Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Obexelimab in Acquired (Autoimmune) Hemolytic Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Obexelimab in Acquired (Autoimmune) Hemolytic Anemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Obexelimab in Acquired (Autoimmune) Hemolytic Anemia Drug Details: Obexelimab...
-
Product Insights
W. Orange Rd Solar PV Park
W. Orange Rd Solar PV Park is a solar PV project located in Massachusetts, United States. The project is owned by The AES Corp and was developed by AES Distributed Energy Inc. The project came online in 2021. Empower your strategies with our W. Orange Rd Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Dupilumab in Grass Pollen Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dupilumab in Grass Pollen Allergy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dupilumab in Grass Pollen Allergy Drug Details: Dupilumab (REGN-668, SAR231893, Dupixent,...